In our previous reports on the role of VEGF and its inhibitor soluble VEGF receptor-2 (sVEGFR-2), we have also shown that higher concentrations of proangiogenic factors may be found in the tears of patients with scleroderma compared with patients’ blood serum and control group [15]. The gene discussed is VEGFA; the disease is scleroderma.